TGFB1 and pulmonary arterial hypertension: Although the incidence of PAH is lower in carriers of genetic mutations, PAH induced by the activation of the TGF-β signaling pathway may be linked to the interaction of EC heterogeneity, genetic modifications, and environmental factors.